Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
282 USD | +0.76% | +1.75% | -12.67% |
04-29 | RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474 | MT |
04-26 | Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group | CI |
Official Publications
SEC Filing 8K | CO | |
Proxy Statments | CO | |
Changes in management and corporate officers | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10K | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10Q-3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Official Publications